閉場中RVOL 0.4xDV $626,21520日平均DV $2M?
決算 2027-03-1152週高値比 -83.2%52週安値比 +66.7%Fwd PER 0.4x時価総額 $5M平均出来高 2.2M
会社概要
Cerenome, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
決算・業績
決算実績
| 期間 | EPS | 売上 | FCF |
|---|
| 2026 Q3 | -1.14 | $722,000 | -$8M |
| 2026 Q2 | -1.33 | $411,000 | -$8M |
| 2026 Q1 | -1.05 | $1M | -$7M |
| 2025 Q4 | -1.04 | $1M | -$6M |
| 2025 Q3 | -1030.00 | $1M | -$3M |
| 2025 Q2 | 615.00 | $1M | -$6M |
| 2025 Q1 |
現在ベータテスト中 → 招待コードでログイン